000			02063 a2200553 4500
005			20250514022439.0
264		0	_c20020131
008			200201s 0 0 eng d
022			_a0277-3732
024	7		_a10.1097/00000421-200112000-00004 _2doi
040			_aNLM _beng _cNLM
100	1		_aColon-Otero, G
245	0	0	_aA phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group Trial. _h[electronic resource]
260			_bAmerican journal of clinical oncology _cDec 2001
300			_a551-5 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAminopterin _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFilgrastim
650	0	4	_aGranulocyte Colony-Stimulating Factor _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aRecombinant Proteins
650	0	4	_aRemission Induction
650	0	4	_aSickness Impact Profile
650	0	4	_aSurvival Analysis
650	0	4	_aVinblastine _xadministration & dosage
700	1		_aNiedringhaus, R D
700	1		_aHillman, S H
700	1		_aGeyer, S
700	1		_aSloan, J
700	1		_aKrook, J E
700	1		_aWindschitl, H E
700	1		_aMarks, R S
700	1		_aWiesenfeld, M
700	1		_aTschetter, L K
700	1		_aJett, J J
773	0		_tAmerican journal of clinical oncology _gvol. 24 _gno. 6 _gp. 551-5
856	4	0	_uhttps://doi.org/10.1097/00000421-200112000-00004 _zAvailable from publisher's website
999			_c11712645 _d11712645